Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. CHU UCL Namur - Site Godinne

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

CHU UCL Namur - Site Godinne is a premier university teaching hospital and a cornerstone academic hub of the CHU UCLouvain Namur network. Initially established as a major regional healthcare facility, it merged into its current university network structure in 2015 and serves as an official clinical training and research campus for UCLouvain.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. University hospital

Business Subcategory

Source: Human-provided. University hospital
Source: Human-provided. Dermatologist
Source: Human-provided. Hospital
Source: Trial-derived.
72Total Trials
Source: Trial-derived.
12Recruiting Trials
Source: Trial-derived.
29Active Trials
Source: Trial-derived.
29Completed Trials
Source: Trial-derived.
100Unique Conditions
Source: Trial-derived.
104Unique Sponsors

Conditions

Source: Trial-derived. Hodgkin Lymphoma (3)Source: Trial-derived. Multiple Myeloma (3)Source: Trial-derived. Breast Cancer (2)Source: Trial-derived. Candidemia (2)Source: Trial-derived. Diffuse Large B-cell Lymphoma (2)Source: Trial-derived. Idiopathic Pulmonary Fibrosis (2)Source: Trial-derived. Lymphoma, Non-Hodgkin (2)Source: Trial-derived. Metastatic Colorectal Cancer (2)

Sponsors

Source: Trial-derived. The Lymphoma Academic Research Organisation (6)Source: Trial-derived. Amgen (4)Source: Trial-derived. Basilea Pharmaceutica (4)Source: Trial-derived. Cliniques universitaires Saint-Luc- Université Catholique de Louvain (4)Source: Trial-derived. Merck Sharp & Dohme LLC (4)Source: Trial-derived. University Hospital of Mont-Godinne (4)Source: Trial-derived. University of Liege (4)Source: Trial-derived. Centre Hospitalier Universitaire UCLouvain Namur (3)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. Full pulmonary function lab (DLCO / plethysmography)
Source: AI-inferred. Six-minute walk test
Source: AI-inferred. Spirometry
Source: AI-inferred. CT Scan

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. ELISA / immunoassay
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Pharmacokinetic bioanalysis

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Blood transfusion service
Source: AI-inferred. Intensive care (ICU)
Source: AI-inferred. Invasive mechanical ventilation

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Chest radiological imaging
Source: AI-inferred. PIK3CA mutation testing of tumour tissue
Source: AI-inferred. Respiratory virus diagnostic testing
Source: AI-inferred. Supplemental oxygen administration